Assembly Biosciences (FRA:V7B) Accounts Payable : €1.20 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences Accounts Payable?

Assembly Biosciences's Accounts Payable for the quarter that ended in Sep. 2024 was €1.20 Mil.

Assembly Biosciences's quarterly Accounts Payable increased from Mar. 2024 (€0.67 Mil) to Jun. 2024 (€0.74 Mil) and increased from Jun. 2024 (€0.74 Mil) to Sep. 2024 (€1.20 Mil).

Assembly Biosciences's annual Accounts Payable stayed the same from Dec. 2021 (€2.35 Mil) to Dec. 2022 (€2.35 Mil) but then declined from Dec. 2022 (€2.35 Mil) to Dec. 2023 (€0.42 Mil).

Assembly Biosciences Accounts Payable Historical Data

The historical data trend for Assembly Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assembly Biosciences Accounts Payable Chart

Assembly Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1.56

3.78

2.35

0.42

Assembly Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															0.71	0.42	0.67	0.74	1.20

Assembly Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Assembly Biosciences Accounts Payable Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Assembly Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ASMB:USA

Address

Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080

Website

https://www.assemblybio.com

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Assembly Biosciences Headlines

No Headlines